VISUS THERAPEUTICS
Visus Therapeutics is a clinical-stage company developing innovative medicines to improve the vision for people around the world.
VISUS THERAPEUTICS
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2019-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.visustx.com
Total Employee:
11+
Status:
Active
Total Funding:
56 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
![]()
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
![]()
Cellerant Therapeutics
Cellerant Therapeutics is a clinical-stage company developing innovative cell- and antibody-based immunotherapies.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Lyra Therapeutics
Lyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Current Advisors List
![]()
Current Employees Featured
![]()
Founder
![]()
Investors List
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Debt Financing - Visus Therapeutics
Life Sciences Partners
Life Sciences Partners investment in Debt Financing - Visus Therapeutics
![]()
RTW Investments LLC
RTW Investments LLC investment in Series A - Visus Therapeutics

Wille AG
Wille AG investment in Series A - Visus Therapeutics
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Series A - Visus Therapeutics
Key Employee Changes
Official Site Inspections
http://www.visustx.com Semrush global rank: 5.1 M Semrush visits lastest month: 1.61 K
- Host name: 104.21.41.27
- IP address: 104.21.41.27
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
